医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

SCC Soft Computer’s Blood Bank Product Receives 510(k) Clearance from the U.S. Food and Drug Administration

2021年01月20日 AM12:00
このエントリーをはてなブックマークに追加


 

CLEARWATER, Fla.

SCC Soft Computer’s SoftBank.web™ version 25.6 received 510(k) clearance from the U.S. Food and Drug Administration (FDA).

SoftBank.web™ has enhanced features to increase productivity in the laboratory while maintaining compliance with safety regulations. The 510(k) cleared SoftBank.web™ enables the delivery of a web-based user interface allowing SoftBank.web™ to be accessed using your web browser, with business logic running on either LINUX or IBM AIX operating systems.

New features such as an enhanced display with vibrant icons provide users ease of system navigation. Facilities can further modify the display to their specific preferences with the introduction of added customizations. The new dashboard features provide system options and sub-options in customizable tiles at the user’s fingertips. These advanced benefits were introduced to increase workflow efficiency and enhance the user experience.

SoftBank.web™ is a centralized transfusion service management system combining previous high-performance functionality with exciting new features to provide a comprehensive, cost-effective centralized testing solution. SCC’s Blood Services Information Systems Suite® has multi-site capabilities and accurate tracking of blood products from a centralized inventory with dynamic features including outstanding management reports, daily trace, and audit trail, to ensure safe, secure, accurate handling of blood products. This suite offers a wide range of exceptional features designed to streamline many of the routine, manual, and time-consuming tasks associated with blood bank and blood donor protocols. As a major asset to the laboratory, SoftBank.web™ provides critical safety functions throughout the system allowing the laboratory’s focus to remain on providing safe blood components, and derivative products to patients. For more information on SoftBank.web™, please contact Ellie Vahman, ellie@softcomputer.com or (727) 789-0100 ext. 4052.

This web-enabled version will enhance the user’s experience both from a visual aesthetic perspective while also providing additional flexibility in user setup, reports, dashboard, and other components for which we know are important to our SoftBank® users.

Gilbert Hakim, CEO, SCC Soft Computer

About SCC Soft Computer

At the forefront of laboratory, genetics, outreach, and blood services information systems software development, since 1979, SCC Soft Computer has designed, developed, delivered, supported, and implemented full suites of powerful integrated laboratory and genetics information management system solutions for hospitals, large integrated delivery networks, and laboratories. To learn more, visit http://www.softcomputer.com/.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210119005166/en/

CONTACT

Ms. Ellie Vahman

SCC Soft Computer

727.789.0100 x4052

ellie@softcomputer.com

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  •  Celltrion’s monoclonal antibody treatment for COVID-19, regdanvimab (CT-P59) becomes the first authorized COVID-19 treatment approved from the Korean Ministry of Food and Drug Safety (MFDS)
  • ENHERTU® Reduced the Risk of Disease Progression or Death by 72% Versus Trastuzumab Emtansine (T-DM1) in Patients with HER2 Positive Metastatic Breast Cancer
  • ENHERTU® Demonstrated Clinically Meaningful and Durable Response in Patients with HER2 Positive Advanced Gastric Cancer in DESTINY-Gastric02 Phase 2 Trial
  • 武田的EXKIVITY™ (mobocertinib)成为美国FDA首次核准的专为EGFR外显子20插入+ NSCLC患者设计的口服治疗药物
  • Masimo上市单例患者使用的rainbow® SuperSensor™